Search Results - "Dorababu, Patchava"

Classification and regression tree-based prediction of 6-mercaptopurine-induced leucopenia grades in children with acute lymphoblastic leukemia by Naushad, Shaik Mohammad, Dorababu, Patchava, Rupasree, Yedluri, Pavani, Addepalli, Raghunadharao, Digumarti, Hussain, Tajamul, Alrokayan, Salman A., Kutala, Vijay Kumar

“…Purpose The rationale of the current study was to develop 6-mercaptopurine (6-MP)-mediated hematological toxicity prediction model for acute lymphoblastic…”
Get full text

Association of NUDT15 c.415C>T and FPGS 2572C>T Variants with the Risk of Early Hematologic Toxicity During 6-MP and Low-Dose Methotrexate-Based Maintenance Therapy in Indian Patients with Acute Lymphoblastic Leukemia by Kodidela, Sunitha, Dorababu, Patchava, Thakkar, Dimpal N., Dubashi, Biswajit, Sundaram, Rajan, Muralidharan, Niveditha, Nidanapu, Ravi Prasad, Aribandi, Anil, Pradhan, Suresh Chandra, Uppugunduri, Chakradhara Rao Satyanarayana

“…Genetic variants influencing the pharmacokinetics and/or pharmacodynamics of the chemotherapeutic drugs used in Acute Lymphoblastic Leukemia (ALL) therapy…”
Get full text

Association of NUDT15 3 and FPGS 2572C>T Variants with the Risk of Early Hematologic Toxicity During 6-MP and Low-Dose Methotrexate-Based Maintenance Therapy in Indian Patients with Acute Lymphoblastic Leukemia by Kodidela, Sunitha, Dorababu, Patchava, Thakkar, Dimpal N, Dubashi, Biswajit, Sundaram, Rajan, Muralidharan, Niveditha, Nidanapu, Ravi Prasad, Aribandi, Anil, Pradhan, Suresh Chandra, Uppugunduri, Chakradhara Rao Satyanarayana

“…Genetic variants influencing the pharmacokinetics and/or pharmacodynamics of the chemotherapeutic drugs used in Acute Lymphoblastic Leukemia (ALL) therapy…”
Get full text